Pharmaceutical and medtech sponsors: access 8 million patients across 100+ GP practices through a single, organised delivery partner.
Our record is first patient enrolled within 2 weeks of contract signing. We placed 250 recruitment posters across the network in 4 days. When you need to move, we move.
Over 8 million patients across PCRA member practices. Real-world, community populations — the patients your trial actually needs to reach, not just those who happen to attend hospital clinics.
MHRA, GCP, HRA and REC compliant. Experienced principal investigators. Established data sharing agreements. You get research-ready sites, not sites that need building from scratch.
Phase II–IV interventional studies in GP settings. Experienced PIs, trained research nurses, dedicated trial space and compliant data systems.
Observational, retrospective and prospective RWE studies using EMIS and SystmOne EHR data across consented practice populations.
No REC required. Rapid setup under 2 weeks. Ideal for device evaluations, vaccine assessments and service improvement studies in real clinical settings.
Participant Identification Centre (PIC) services — we screen, identify and refer eligible patients to your trial sites, fast.
Specialist access to chronic wound patient populations managed in primary care. Unique expertise in wound healing study design and delivery.
GP practices are the natural home for vaccine studies. Access to defined patient groups, established immunisation infrastructure, and community trust.
Asthma, COPD, and respiratory infection — conditions managed almost entirely in primary care, with rich longitudinal EHR data.
GPwER dermatology leads across the network, with access to skin condition patient cohorts and established diagnostic pathways.
Contraception, menopause, gynaecology — conditions where primary care is the first and most frequent point of contact.
Diabetes, hypertension, obesity and cardiovascular risk — the bread and butter of primary care, with large, well-characterised patient registers.
Contact the Primary Care Research Alliance. Tell us about your trial and we'll tell you what's possible — and how fast.
Talk to PCRA →